A hypoglossal nerve stimulation implant is a new treatment for sleep apnea. It replaces the traditional continuous positive airway pressure (CPAP) machine therapy in people who have not had success ...

While Obstructive Sleep Apnea (OSA) affects about five percent of the general pediatric population, 80 percent of children with Down syndrome experience OSA. Continual OSA results in poor health, ...

Sleep apnea, or difficulty breathing at night, is common among children with Down syndrome—affecting up to 80% compared to just 5% of the general pediatric population. Sleep apnea can negatively ...

Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and corresponding author and Brian Skotko, MD, MPP, the director of the Down ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up ...

Use of hypoglossal nerve stimulation (HGNS) may be effective for treating obstructive sleep apnea (OSA), but a higher body mass index (BMI) and supine sleeping position may decrease effects, according ...

An implant for obstructive sleep apnea — a serious sleep malady in which breathing stops for 10 seconds to two minutes many times an hour each night — works best in people who are overweight but not ...

To qualify for the device, called a hypoglossal nerve stimulator, a person over 18 diagnosed with moderate-to-severe obstructive sleep apnea must be unable to adapt or refuse to wear a continuous ...

CHICAGO -- An investigational proximal hypoglossal nerve stimulation device helped control obstructive sleep apnea (OSA), the OSPREY randomized trial showed. The Apnea-Hypopnea Index (AHI) response ...

LivaNova is poised to become Inspire Medical's first competitor in the United States with a fully implantable neurostimulation device for obstructive sleep apnea. London, England-based LivaNova ...

Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and corresponding author and Brian Skotko, MD, MPP, the director of the Down ...